Hans Moebius - Net Worth and Insider Trading

Hans Moebius Net Worth

The estimated net worth of Hans Moebius is at least $167,223 dollars as of 2024-05-22. Hans Moebius is the Chief Medical Officer of Athira Pharma Inc and owns about 65,836 shares of Athira Pharma Inc (ATHA) stock worth over $167,223. Details can be seen in Hans Moebius's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hans Moebius has not made any transactions after 2022-11-15 and currently still holds the listed stock(s).

Transaction Summary of Hans Moebius

To

Hans Moebius Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hans Moebius owns 1 companies in total, including Athira Pharma Inc (ATHA) .

Click here to see the complete history of Hans Moebius’s form 4 insider trades.

Insider Ownership Summary of Hans Moebius

Ticker Comapny Transaction Date Type of Owner
ATHA Athira Pharma Inc 2022-11-15 Chief Medical Officer

Hans Moebius Latest Holdings Summary

Hans Moebius currently owns a total of 1 stock. Hans Moebius owns 65,836 shares of Athira Pharma Inc (ATHA) as of November 15, 2022, with a value of $167,223.

Latest Holdings of Hans Moebius

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATHA Athira Pharma Inc 2022-11-15 65,836 2.54 167,223

Holding Weightings of Hans Moebius


Hans Moebius Form 4 Trading Tracker

According to the SEC Form 4 filings, Hans Moebius has made a total of 2 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 5,000 shares on November 15, 2022, which cost Hans Moebius around $16,450.

Insider Trading History of Hans Moebius

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hans Moebius Trading Performance

GuruFocus tracks the stock performance after each of Hans Moebius's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hans Moebius is 11.13%. GuruFocus also compares Hans Moebius's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hans Moebius within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hans Moebius's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hans Moebius

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.28
Relative Return to S&P 500(%) 12.2

Hans Moebius Ownership Network

Ownership Network List of Hans Moebius

No Data

Ownership Network Relation of Hans Moebius


Hans Moebius Owned Company Details

What does Athira Pharma Inc do?

Who are the key executives at Athira Pharma Inc?

Hans Moebius is the Chief Medical Officer of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .

Athira Pharma Inc (ATHA) Insider Trades Summary

Over the past 18 months, Hans Moebius made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Kevin Church .

In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 795,698 shares were bought by its insiders, resulting in a net purchase of 769,170 shares.

Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Athira Pharma Inc Insider Transactions

No Available Data

Hans Moebius Mailing Address

Above is the net worth, insider trading, and ownership report for Hans Moebius. You might contact Hans Moebius via mailing address: 4000 Mason Road, Suite 300, Box 352141, Seattle Wa 98195-2141.

Discussions on Hans Moebius

No discussions yet.